BitPay and Banxa Partner to Expand Crypto Payment Options Globally

BitPay, one of the world's largest providers of Bitcoin and cryptocurrency payment services, has announced a partnership with Banxa, a global payments infrastructure provider for the crypto-compatible economy. 


The partnership will enable BitPay users across multiple countries to buy and sell cryptocurrencies using local payment methods.


More Crypto Payment Options for BitPay Users


Banxa offers a range of local payment methods, such as bank transfers, e-wallets, QR codes, and cash vouchers, that are more convenient and secure than traditional methods. Banxa also complies with global regulatory requirements and obtains necessary licenses to operate in different jurisdictions.


BitPay and Banxa support the sale of over 175 cryptocurrencies across 20 chains, including Bitcoin (BTC), Ether (ETH), Litecoin (LTC), Polygon (MATIC), and dozens more. Users can buy and manage cryptocurrencies within the BitPay Wallet app or send them directly to an alternative self-custody wallet from the BitPay website.


The partnership will benefit cryptocurrency communities across the Americas, Europe, Asia, Africa, and Oceania, who can now access new payment methods such as iDEAL in the Netherlands, SEPA in Europe, ACH in the US, Interac in Canada, Faster Payments System in the UK, PayID in Australia, PIX in Brazil, and many more.


Also ReadHackers Steal Sensitive Information in Okta Data Breach


"BitPay is excited to partner with Banxa to offer our users more ways to buy and sell cryptocurrencies with ease and convenience. Banxa shares our vision of making crypto more accessible and usable for everyone," said Stephen Pair, CEO of BitPay.


"Banxa is thrilled to partner with BitPay, one of the pioneers and leaders in the crypto payment space. Together, we are expanding the payment methods available to BitPay users and enabling them to enjoy a seamless buying journey for crypto assets," said Holger Arians, CEO of Banxa.

Don't Spam in Comment's !!

Post a Comment (0)
Previous Post Next Post